Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

AC Immune SA

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
3.97+0.0700+1.79%Vol 233 1711Y Perf -65.53%
Feb 15th, 2019 16:00
BID3.91 ASK3.97
Open3.93 Previous Close3.90
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.33 
Analyst Rating
Strong Buy 1.50
Potencial %
210.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★ —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     47.16
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)261 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
5.09 
Earnings Date
19th Mar 2019

Today's Price Range

3.893.97

 

52wk Range

3.2517.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-65.45%
3 Months
-59.37%
6 Months
-54.68%
1 Year
-65.53%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACIU3.970.07001.79
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
19.00
Current Ratio
19.20
Long Term Debt to Total Capital
0.00
Total Debt to Equity
0.00
Interest Coverage
-251.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-144.00
EBITDA Margin
-140.10
Pre-tax Profit Margin
-40.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.38
PS Ratios
44.78
Price to Cash Flow
35.80
Price to Free Cash Flow
-7.60
Cash Flow Per Share
-0.44
Price to Tangible Book
1.35
Book Value per Share
2.84
Enterprise Value (in ths.)
66 048
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-21.02
Return on Assets (5Y Avg)
-
ROA last 12 Months
-19.16
Return on Capital (5Y Avg)
7.55
ROC last 12 Months
-21.15
Return on invested Capital Q
-9.35
Return on invested Capital Y
-20.46
Assets Turnover
0.00
Receivables Turnover
1.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
5 897
Revenue per Share
0.09
Revenue Growth 3 Years
-38.82
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.27-0.1929.63
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR0.53296.30Positive
12/2018 QR-0.270.00-
12/2018 FY-0.0198.92Positive
12/2019 FY-0.3167.02Positive
Next Report Date19th Mar 2019
Estimated EPS Next Report0.53
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume233 171
Shares Outstanding (in ths.)65 863
Trades Count668
Dollar Volume879 560
Avg. Volume836 600
Avg. Weekly Volume358 942
Avg. Monthly Volume1 212 806
Avg. Quarterly Volume517 207

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

52%48%

Bearish Bullish

63%37%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
4 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News